ArticleFrontiers in pharmacology2020

Specific TLR4 Blocking Effect of a Novel 3,4-Dihydropyrimidinone Derivative.

Mingqian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.